Spring 2024 Seed Grant Funding Cycle is open. Click to learn more!
Applications are due on April 15.
Dunlevie Maternal-Fetal Medicine Center
Empowering an arc of research and discovery in maternal-fetal health.
Dunlevie Maternal-Fetal Medicine Center for Discovery, Innovation and Clinical Impact, established in 2021 through a philanthropic donation by Elizabeth and Bruce Dunlevie, reimagines high-risk obstetrics by launching a bold and comprehensive research program to transform the health of pregnant patients and their babies. The Center enhances the existing world-class maternal-fetal medicine and obstetrics program at Stanford Medicine by focusing research and new faculty hires on emerging priorities in the field.
You're invited to "Advancements and Innovations: Exploring Emerging Medical Treatments in Fetal Therapy"
Our Spring symposium on May 2nd will highlight recent advancements in fetal medical therapies for genetic, structural, and infectious conditions.
News & Updates
Dunlevie Center Monthly Research Meetings, Second Thursday at Noon
Dr. Nima Aghaeepour will present "AI-Driven Integration of Omics, EHR, and Wearable Devices for Maternal and Child Health" at our monthly research meeting on April 11.
Meet the Fall 2023 Seed Funding Awardees
Two researchers, Andrea Henkel, MD, MS, and Kristy Red-Horse, PhD, received funding for their proposals. Learn more about their work.
Stanford Named a New NIH Maternal Health Research Center of Excellence
Stanford PRIHSM (PReventing Inequities in Hemorrhage-related Severe Maternal morbidity) will work to reduce one of the leading causes of maternal morbidity and severe maternal morbidity: postpartum hemorrhage.
Center Research
Priorities are based on four research areas:
- Basic Science Discovery
- Prenatal Diagnosis and Fetal Therapy
- Clinical Trials (Obstetrical, Medical, and Surgical)
- Perinatal Epidemiology and Population Health
These research areas are supported by a dedicated Research Core that provides critical infrastructure in research administration, biostatistics, writing and communications, study coordination and laboratory expertise. The ultimate objective is to rapidly accelerate discovery in the science and practice of high-risk obstetrics for families locally, nationally, and globally, and to pursue research that crosses socioeconomic boundaries and advances health equity.
About the Center
The momentous and transformative gift from Elizabeth and Bruce Dunlevie will allow us to advance Maternal-Fetal Medicine Science and Practice locally at Stanford, nationally and globally. This gift will positively and profoundly impact the health and wellbeing of expectant mothers, children and families everywhere and for generations to come.
Yasser El-Sayed, MD
Center Director